Literature DB >> 30201524

Post-Mortem Evaluation of Potentially Survivable Hemorrhagic Death in a Civilian Population.

Craig Goolsby1, Elizabeth Rouse2, Luis Rojas3, Eric Goralnick4, Matthew J Levy5, Thomas Kirsch3, Alexander L Eastman6, Arthur Kellermann7, Kandra Strauss-Riggs3, Nicole Hurst8.   

Abstract

BACKGROUND: Although the survivability of military extremity hemorrhage is well documented, equivalent civilian data are limited. We analyzed statewide autopsy records in Maryland to determine the number of hemorrhagic deaths that might have been potentially survivable with prompt hemorrhage control. Similar analyses of battlefield deaths led to life-saving changes in military medical practice. STUDY
DESIGN: This is a retrospective study of decedent records. The objective is to estimate the number of hemorrhagic deaths that might have been prevented by prompt placement of an extremity tourniquet. Maryland autopsy records from 2002 to 2016 were selected using the following search terms: amputation, arm/arms, avulsion, exsanguination, extremity/extremities, leg/legs. The records were analyzed by applying a checklist of previously developed military criteria to characterize deaths as potentially survivable or nonsurvivable with prompt use of a tourniquet. Suicides and decedents less than 18 years old were excluded. The study did not use information about living participants. Two expert reviewers independently evaluated and scored the death records. Deaths were classified as either potentially survivable or nonsurvivable. A third reviewer broke any ties.
RESULTS: There were 288 full autopsy records included in the final analysis. Of the eligible decedents reviewed during the 14-year period, 124 of 288 had potentially survivable wounds; 164 had nonsurvivable wounds.
CONCLUSIONS: Over the 14-year study interval, 124 Maryland decedents-an average of 9 per year-might have been saved with prompt placement of a tourniquet. If extrapolated, approximately 480 people in the US might be saved per year. These results provide evidence to support educating and equipping the public to provide bleeding control. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2018        PMID: 30201524     DOI: 10.1016/j.jamcollsurg.2018.08.692

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  6 in total

1.  Recommended Process Outcome Measures for Stop the Bleed Education Programs.

Authors:  Kandra Strauss-Riggs; Thomas D Kirsch; Erik Prytz; Richard C Hunt; Carl-Oscar Jonson; Jon Krohmer; Ira Nemeth; Craig Goolsby
Journal:  AEM Educ Train       Date:  2020-04-16

2.  Initial acuity of firearm injuries in the United States: are civilian injuries similar to combat casualty statistics.

Authors:  Daniel Stephen Schwartz; Jonah Thompson; Tony Locrotondo; Spencer Heggers
Journal:  Intern Emerg Med       Date:  2021-08-11       Impact factor: 3.397

3.  The FAST VIP (First Aid for Severe Trauma "Virtual" in-Person) Educational Study.

Authors:  Craig A Goolsby; Keke Schuler; Raphaelle Rodzik; Nathan Charlton; Vidya Lala; Kevin Anderson; Jeffrey L Pellegrino
Journal:  West J Emerg Med       Date:  2021-06-29

4.  Visual estimates of blood loss by medical laypeople: Effects of blood loss volume, victim gender, and perspective.

Authors:  Rachel Phillips; Marc Friberg; Mattias Lantz Cronqvist; Carl-Oscar Jonson; Erik Prytz
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

5.  Potentially survivable fatal vascular access hemorrhage with tourniquet use: A post-mortem analysis.

Authors:  Craig Goolsby; Luis E Rojas; Michael Andersen; Nathan Charlton; Laura Tilley; Jason Pasley; Todd E Rasmussen; Matthew J Levy
Journal:  J Am Coll Emerg Physicians Open       Date:  2020-08-17

6.  Robotically applied hemostatic clamping for care-under-fire: harnessing bomb robots for hemorrhage control.

Authors:  Andrew W Kirkpatrick; Ian A McKee; Brian Knudsen; Ryan Shelton; Anthony J LaPorta; Juan Wachs; Jessica L McKee
Journal:  Can J Surg       Date:  2022-04-01       Impact factor: 2.089

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.